Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
307 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urinary Bladder Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns
Conditions: Multiple Sclerosis;   Urinary Bladder Diseases
Intervention: Behavioral: Systematic Screening and Education Regimen
2 Recruiting A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Conditions: Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: Mirabegron;   Drug: Solifenacin succinate low dose;   Drug: Solifenacin succinate high dose
3 Not yet recruiting SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I
Conditions: Urinary Bladder Neoplasms;   Urologic Neoplasms;   Urogenital Neoplasms;   Neoplasms;   Neoplasms by Site;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
4 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
5 Recruiting Investigating Three-Dimensional Versus Two-Dimensional Imaging in Laparoscopic Cholecystectomies
Condition: Gall Bladder Disease
Intervention: Device: Laparoscopic visual system
6 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
7 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
8 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
9 Not yet recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
10 Recruiting Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer;   Melanoma;   Renal Cell Carcinoma;   Triple-negative Breast Cancer;   Head and Neck Cancer;   Bladder Cancer;   Non-small Cell Lung Cancer
Intervention: Biological: MGA271
11 Recruiting Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer
Condition: Relapsed Bladder Cancer
Intervention: Drug: TORISEL
12 Recruiting Efficacy and Safety of AQX-1125 in IC/BPS
Conditions: Interstitial Cystitis;   Bladder Pain Syndrome
Intervention: Drug: AQX-1125
13 Recruiting The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
Condition: Interstitial Cystitis
Intervention: Drug: Hyaluronic acid/chondroitin sulfate
14 Not yet recruiting Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder
Condition: Urinary Tract Infection
Interventions: Other: Antibiotic;   Drug: Probiotic
15 Recruiting S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: therapeutic conventional surgery;   Procedure: therapeutic lymphadenectomy
16 Recruiting Systemic Treatment of Resistant Metastatic Disease
Conditions: Non-small Cell Lung Cancer;   Castrate-resistant Prostate Cancer;   Melanoma;   Bladder Cancer
Intervention: Biological: CVA21
17 Not yet recruiting Comparison of Two Insertion Technique of I-gel
Conditions: Prostate Cancer;   Prostate Tumor;   Bladder Cancer;   Bladder Tumor
Intervention: Procedure: Rotational technique
18 Recruiting Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer
Conditions: Bladder Cancer;   High Risk Superficial
Intervention: Biological: Bacillus Calmette-Guérin (BCG)
19 Recruiting Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients
Conditions: Interstitial Cystitis;   IC
Intervention: Device: TC-3 Gel mixed with Botox (BTX)
20 Recruiting The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome
Condition: Interstitial Cystitis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years